Read + Share
Amedeo Smart
Independent Medical Education
Wiemken TL, Rutschman AS. Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic. Vaccine 2021 Jan 9. pii: S0264-410X(21)00018.PMID: 33461832
Email
LinkedIn
Facebook
Twitter
Privacy Policy